Huffington Magazine Issue 80 | Page 55

BRAVE NEW WORLD particles. The idea was to target the drug and avoid the side effects of paclitaxel. There were medical skeptics, and others who questioned SoonShiong’s business practices as he built his pharmaceutical empire. He once settled a corporate case out of court with his own brother. His pride and salesmanship occasionally clash with scientific caution. The FDA once ordered him to tone down promotional claims about his nanotechnology standards. Early in his career, he touted a diabetes treatment based on what turned out to be only a temporary success with a single patient. But the FDA first approved the Abraxane technique in 2005. Abraxane is now approv